Boehringer Ingelheim and Microsoft Partner on AI Clinical Trials
Boehringer Ingelheim and Microsoft have partnered to advance AI-driven clinical development, using Digital Patient Twins to accelerate safer and more effective therapies.
AI-Driven Clinical Development | 24/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy